HILS

Hillstream BioPharma, Inc. HILS

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HILS TNFA GMDA APTO GRTS CYTO VIVS NBRVF BCEL ONCO
6M -72.12 % -72.92 % 0.00 % 0.00 % -96.06 % 327.96 % 31.97 % 0.00 % -74.75 % -60.79 %
YTD -30.50 % -95.48 % 0.00 % -75.81 % -98.52 % 145.90 % 12.79 % 0.00 % -31.14 % -97.14 %
1Y -63.65 % -97.08 % 0.00 % -77.08 % -97.56 % 212.76 % 12.79 % 0.00 % -90.72 % -94.67 %
3Y -93.19 % -97.28 % -98.29 % -98.35 % -99.69 % -99.68 % 12.79 % -99.99 % -98.87 % -99.95 %
5Y -93.19 % -97.28 % -99.27 % -99.82 % -99.61 % -99.97 % 12.79 % -99.99 % -99.45 % -100.00 %
10Y -93.19 % -97.28 % -99.61 % -99.72 % -99.77 % -100.00 % 12.79 % -99.99 % -99.50 % -100.00 %
From the beginning -93.19 % -97.28 % -99.61 % -100.00 % -99.77 % -100.00 % 12.79 % -99.99 % -99.50 % -100.00 %

Dividend